Practical Management of Everolimus-Related Toxicities in Patients with Advanced Solid Tumors

Publisher： Karger

E-ISSN： 2296-5262|36|5|295-302

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.36, Iss.5, 2013-04, pp. : 295-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metronomic Oral Cyclophosphamide in Patients with Advanced Solid Tumors

By  

Oncology Research and Treatment, Vol. 35, Iss. 1-2, 2012-01 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

Dose Escalation Study on Oxaliplatin and Capecitabine (Xeloda) in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 253-259

Karger

Access to resources Recommend Favorite

A Dose-Escalation Study of Oxaliplatin and Vinorelbine in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 213-218

Karger

Access to resources Recommend Favorite

Population pharmacokinetics modeling and analysis of foretinib in adult patients with advanced solid tumors

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1184-1192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lipid‐lowering therapy of everolimus‐related severe hypertriglyceridaemia in a pancreatic neuroendocrine tumour (pNET)

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 114-116

John Wiley & Sons Inc

Access to resources Recommend Favorite